Literature DB >> 28756637

Sputum bacteriology and clinical response to antibiotics in moderate exacerbation of chronic obstructive pulmonary disease.

Seung Won Ra1, Yong Soo Kwon2, Sung Ho Yoon3, Chi Young Jung4, Jusang Kim5, Hye Sook Choi6, Seung Soo Sheen7, Hun Gyu Hwang8, Ji-Hyun Lee9, Tae-Hyung Kim10.   

Abstract

BACKGROUND: Presence of purulent sputum during an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is considered sufficient indication for starting empirical antibiotics. We investigated the relationship between detection of potentially pathogenic bacteria (PPB) using sputum culture or polymerase chain reaction (PCR) and clinical response and sought the risk factors for PPB growth.
METHODS: In 342 outpatients with AECOPD, we compared detection rates of H. influenzae (HI) and S. pneumoniae (SP) using conventional sputum culture versus PCR. The utility of either technique to predict clinical cure or failure after effective antibiotics was assessed. The factors predicting positive sputum cultures were evaluated using logistic regression.
RESULTS: Using sputum culture, 132 PPB were detected. The predominant bacteria were HI (40.9%) and SP (19.7%). Detection of HI or SP in sputum was higher using PCR than culture growth (60.8% vs 18.6%; P < .001). Clinical response was not affected by the results of either technique. Independent risk factors for PPB isolation were Gram-negative bacteria on sputum smear (OR 15.78, 95% CI 6.38-39.06; P < .001), sputum purulence (OR 2.31, 95% CI, 1.05-5.11; P = .04), body temperature (OR 0.16, 95% CI 0.05-0.54; P = .003), albumin level (OR 0.29, 95% CI 0.09-0.88; P = .03) and dyspnea grade (OR 0.51, 95% CI 0.27-0.96; P = .04).
CONCLUSIONS: Neither culture growth nor PCR positivity for HI or SP in sputum predicted clinical response to antibiotics; therefore, these tests are not necessary for outpatients with AECOPD. Examining Gram-staining and purulence on sputum smear, however, was significant to predict PPB growth in sputum.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  bacteria; chronic obstructive pulmonary disease; exacerbation; polymerase chain reaction; sputum culture

Mesh:

Substances:

Year:  2017        PMID: 28756637     DOI: 10.1111/crj.12671

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  5 in total

1.  Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis.

Authors:  George Hoult; David Gillespie; Tom M A Wilkinson; Mike Thomas; Nick A Francis
Journal:  BMC Pulm Med       Date:  2022-05-13       Impact factor: 3.320

2.  Clinical Features and C-Reactive Protein as Predictors of Bacterial Exacerbations of COPD.

Authors:  Nick A Francis; David Gillespie; Mandy Wootton; Patrick White; Janine Bates; Jennifer Richards; Hasse Melbye; Kerenza Hood; Christopher C Butler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-12-01

3.  Exploratory study on classification of chronic obstructive pulmonary disease combining multi-stage feature fusion and machine learning.

Authors:  Junfeng Peng; Mi Zhou; Kaiqiang Zou; Xiongyong Zhu; Jun Xu; Yi Teng; Feifei Zhang; Guoming Chen
Journal:  BMC Med Inform Decis Mak       Date:  2021-12-14       Impact factor: 2.796

4.  Bacterial etiology and pneumococcal urinary antigen in moderate exacerbation of chronic obstructive pulmonary disease.

Authors:  Jungmin Yoo; Chi Young Jung; Ju Ock Na; Tae-Hyung Kim; Yeon-Mok Oh; Seung Won Ra
Journal:  J Thorac Dis       Date:  2022-07       Impact factor: 3.005

Review 5.  Appropriate antibiotic management of bacterial lower respiratory tract infections.

Authors:  Charles Feldman; Guy Richards
Journal:  F1000Res       Date:  2018-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.